Medication Related Burden In Hypertension Patients: A Case Study At Afina Pharmacy Yogyakarta
DOI:
https://doi.org/10.70410/jfg.v11i3.344Keywords:
hypertension, medicine related burdenAbstract
Hypertension is the cause of death in 31.5% (1.39 billion). The prevalence of hypertension is increasing in low- and middle-income countries. The prevalence of hypertension in Yogyakarta reached 35.8%, higher than the national figure (31.7%). Hypertension requires long-term treatment which can cause a burden of treatment on patients. The purpose of this study was to determine the characteristics, treatment patterns and treatment burden of hypertension patients at Afina Pharmacy Yogyakarta. This study is an observational descriptive approach. Data collection was carried out through direct interviews with patients about the burden of treatment with the Living With Medicine Questionaire (LMQ) questionnaire guide. The sample was in accordance with the inclusion and exclusion criteria totaling 31 respondents. Data were analyzed using the descriptive method.The results showed that 26 respondents (83.8%) were in the age group> 46 years, with 23 respondents (74.2%) of whom were female, the respondent's education level was at the SMA-PT level, namely 20 respondents (64.5), and 22 respondents (71%) had a previous history of hypertension.Based on patient therapy patterns, 22 respondents (70.9) used Calcium Channel Blocker class antihypertensives, namely Amlodipine and 18 respondents (58.1%) used Angiotensin Reseptor Blocker class antihypertensives, namely Candesartan 16 mg. Medication Related Burden of hypertension patients at Afina Yogyakarta Pharmacy is in the category of low burden 7 respondents (22.6%) and moderate burden 24 respondents (77.4%).
Downloads
References
Andhyka, I., Sidrotullah, M., & Elvvi, E., 2019, Profil Efektivitas Obat Hipertensi Captopril dan Amlodipin Pada Pasien Hipertensi Rawat Jalan di Wilayah Kerja Puskesmas Selaparang Periode Juni Tahun 2017. Jurnal Ilmu Kesehatan dan Farmasi, 7(1), 5-9.
Akbar, F., Nur, H., & Humaerah, U. I., 2020, Karakteristik Hipertensi Pada Lanjut Usia Di Desa Buku (Characteristics of Hypertension in the Elderly). Wawasan Kesehatan, 5(2), 35-42.
Connelly, P. J., Currie, G., & Delles, C. 2022. Sex differences in the prevalence, outcomes and management of hypertension. Current hypertension reports, 24(6), 185-192.
Depkes., 2018, Riset Kesehatan Dasar. Badan Penelitian dan Pengembangan Kesehatan Kementerian RI tahun 2018. http://www.depkes.go.id/resources/download/infoterkini/materi_rakorpop_2018/Hasil%20Riskesdas%202018.pdf – Diakses 11 Mei 2023
Efendi, H., & Larasati, T., 2017, Dukungan keluarga dalam manajemen penyakit hipertensi. Jurnal Majority, 6(1), 34-40.
Katusiime, B., Corlett, S.A. & Krska, J., 2018, Development and Validation of a Revised Instrument to Measure burden of long-term medicine use: the Living with Medicines Questionnaire version 3. Patient Related Outcomes Measure, Volume 9, pp. 155-168.
Kawulusan, K. B., Katuuk, M. E., & Bataha, Y. B., 2019. Hubungan Self-Efficacy dengan Kepatuhan Minum Obat Hipertensi di Puskesmas Ranotana Weru Kota Manado. Jurnal Keperawatan, 7(1).
Kementerian Kesehatan Republik Indonesia.,2019, Hipertensi Penyakit Paling Banyak Diidap Masyarakat [Internet], Available from : https://www.kemkes.go.id/article/view/19051700002/hipertensi-penyakit-paling-banyak-diidap-masyarakat.html, diakses tanggal 11 Mei 2023
Khotimah SEYN, Musnelina L., 2016. Evaluasi Penggunaan Obat Antihipertensi pada Pasien Hipertensi Primer Usia ? 45 Tahun di Instalasi Rawat Jalan Rumah Sakit Umum Daerah (RSUD) Kota Depok. Sainstech Farma. 2016;9(1):30-34.
Kionowati, K., Mediastini, E., & Septiyana, R.,2018, Hubungan karakteristik pasien hipertensi terhadap kepatuhan minum obat di dokter keluarga kabupaten Kendal. Jurnal Farmasetis, 7(1), 6-11.
Liberty, I. A., Pariyana, P., Roflin, E., & Waris, L., 2017, Determinan kepatuhan berobat pasien hipertensi pada fasilitas kesehatan tingkat I. Jurnal Penelitian dan Pengembangan Pelayanan Kesehatan, 58-65.
Mills, K. T., Stefanescu, A., & He, J. (2020). The global epidemiology of hypertension. Nature Reviews Nephrology, 16(4), 223-237.
Maslakpak MH, Rezaei B, Parizad N. 2018 Does family involvement in patient education improve hypertension management? A single-blind randomized, Parallel Group, controlled trial. Cogent Medicine.;5(1):1537063.
Mamdouh, H., Alnakhi, W. K., Hussain, H. Y., Ibrahim, G. M., Hussein, A., Mahmoud, I., ... & Sulaiman, N. 2022. Prevalence and associated risk factors of hypertension and pre-hypertension among the adult population: findings from the Dubai Household Survey, 2019. BMC Cardiovascular Disorders, 22(1), 18.
Nurkholipah, F., Agustina, L., & Bunga, D. N. F. H., 2024, Hubungan Penerapan Komunikasi Terapeutik Perawat dengan Kepatuhan Kontrol pada Penderita Hipertensi. Jurnal Penelitian Perawat Profesional, 6(4), 1479-1486.
Putra, J. A. K. 2023, Analisis Psikometri Validitas Dan Reliabilitas Instrumen Living With Medicine Questionnaire (LMQ) Versi Bahasa Indonesia terhadap Pasien Hipertensi di Daerah Istimewa Yogyakarta (DIY) (Doctoral dissertation, Universitas Gadjah Mada).
Rachmawati, F. A., Setyawan, F. E. B., & Wartiningsih, M. 2023. Identifikasi Faktor Risiko Peningkatan Kejadian Hipertensi. CoMPHI Journal: Community Medicine and Public Health of Indonesia Journal, 3(3).
Reckelhoff JF. Gender differences in hypertension. Curr Opin Nephrol Hypertens. 2018 May;27(3):176-181. doi: 10.1097/MNH.0000000000000404. PMID: 29406364.
Saleh, G., & Hendra, M. D.,2019, Pengaruh Komunikasi Dokter Terhadap Kesembuhan Pasien Rawat Jalan. Interaksi: Jurnal Ilmu Komunikasi, 8(1), 12-17.
Sharma, J. R., Mabhida, S. E., Myers, B., Apalata, T., Nicol, E., Benjeddou, M., ... & Johnson, R. 2021. Prevalence of hypertension and its associated risk factors in a rural black population of Mthatha Town, South Africa. International Journal of Environmental Research and Public Health, 18(3), 1215.
Supriyanto, Endi. "Pengaruh Aktivitas Fisik Jalan Pagi Terhadap Tekanan Darah Pada Lansia Dengan Penyakit Hipertensi Di Upt Pstw Khusnul Khotimah Pekanbaru." Ensiklopedia of Journal 1, no. 4 (2019).
Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75(6):1334-1357.
Wahyuni, Khurin In.,2021, Hubungan tingkat pengetahuan dengan kepatuhan pasien hipertensi di Rumah Sakit Anwar Medika." Jurnal Ilmiah Farmasi Farmasyifa 4, no. 1: 87-97.
WHO,2019. A Global Brief on Hypertension [Internet]. Geneva: World Health Organization.,2019,Availablefrom:https://www.who.int/cardiovascular_diseases/publications/global_brief_hy pertension/en/
Xie M, Tang T, Liang H.,2023, Efficacy of single-pill combination in uncontrolled essential hypertension: A systematic review and network meta-analysis. Clin Cardiol. Aug;46(8):886-898. doi: 10.1002/clc.24082. Epub 2023 Jul 11. PMID: 37432701; PMCID: PMC10436803.
Downloads
Published
How to Cite
Issue
Section
Citation Check
License
Copyright (c) 2024 Rendy Kurniawan, Woro Supadmi, Rahmar Qifari Nasrun, Dwi Hastuti
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in Jurnal Farmasi Galenika agree to the following terms:
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. CC BY includes the following elements:
BY: credit must be given to the creator.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
